Cyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatment

Area of Science:

• Environmental Science
• Biochemistry
• Toxicology

Background:

• Vanadium compounds, found in air pollution, exhibit dual anticancer and carcinogenic properties.
• Research into vanadium compounds for diabetes and cancer treatment necessitates understanding their inflammatory mechanisms.
• Cyclooxygenases (COX-1 and COX-2) are key enzymes in inflammatory pathways.

Purpose of the Study:

• To investigate the impact of sodium orthovanadate on cyclooxygenase (COX) activity and expression in macrophages.
• To elucidate the role of COX-2 in the observed effects of sodium orthovanadate.

Main Methods:

• PMA-activated THP-1 macrophages were treated with micromolar concentrations of sodium orthovanadate.
• ELISA assays measured prostaglandin E2 and thromboxane B2 levels.
• COX-2 inhibition (NS-398) and Western blotting assessed COX-2 activity and expression.
• Quantitative real-time PCR analyzed PTGS1 and PTGS2 mRNA levels.

Main Results:

• Sodium orthovanadate dose-dependently increased prostaglandin E2 and thromboxane B2 release.
• The observed increase in prostaglandin E2 was independent of COX-2 activity.
• Western blotting indicated increased COX-2 expression when combined with a COX-2 inhibitor.
• No significant changes in PTGS1 or PTGS2 mRNA levels were detected.

Conclusions:

• Sodium orthovanadate influences inflammatory mediators prostaglandin E2 and thromboxane B2 in macrophages.
• The vanadium compound modulates COX-2 expression, but not its activity, in a manner independent of direct COX-2 inhibition.
• Further research is needed to clarify the precise molecular mechanisms underlying vanadium's inflammatory effects.